Active coating of implants used in orthopedic surgery

Practice of Intramedullary Locked Nails: New Developments in Techniques and Applications

Volumn , Issue , 2006, Pages 283-296

  Raschke, Michael J ^a   Fuchs, Thomas ^a   Stange, R ^a   Lucke, Martin ^b   Kandziora, Frank ^b   Wildemann, Britt ^b   Schmidmaier, Gerhard ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891975873     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-32345-7_29     Document Type: Chapter

References (27)

1. Beck A, Kinzl L, Bischoff M (1999) [Antibiotic prophylaxis and therapy in trauma surgery]. Unfallchirurg 102:955-966.
2. Coventry M, Nolan D, Bukenbauch R (1973) "Delayed" prophylactic anticoagulation: a study of results and complications in 2, 012 total hip arthroplasties. J Bone Joint Surg 55:1487-1492.
3. Einhorn TA (1995) Enhancement of fracture healing. J Bone Joint Surg Am 77:940-956.
4. Einhorn TA, Lane JM (1998) Significant advances have been made in the way surgeons treat fractures [editorial]. Clin Orthop S2-S3.
5. Fujimoto R, Tanizawa T, Nishida S, Yamamoto N, Soshi S, Endo N, Takahashi HE (1999) Local effects of transforming growth factor-betal on rat calvaria: changes depending on the dose and the injection site. J Bone Miner Metab 17:11-17.
6. Cristina AG, Costerton JW (1985) Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am 67:264-273.
7. Kandziora F, Pflugmacher R, Scholz M, Schafer J, Schollmeier G, Schmidmaier G, Duda G, Raschke M, Haas NP (2003) Dose-dependent effects of combined IGF-I and TGF-β1 application in a sheep cervical spine fusion model. Eur Spine J 12:464-473.
8. Kandziora F, Bail H, Schmidmaier G, Schollmeier G, Scholz M, Knispel C, Hiller T, Pflugmacher R, Mittlmeier T, Raschke M, Haas NP (2002) Bone morphogenic protein-2 application by a poly (D, L-lactide)-coated interbodycage: in vivo results of a new carrier for growth factors. J Neurosurg (Spine 1) 97:40-48.
9. Kandziora F, Schmidmaier G, Schollmeier G, Bail H, Pflugmacher R, Gorke T, Wagner M, Raschke M, Mittlmeier T, Haas NP (2002) IGF-I and TGF-betal application by a poly-(D, L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine. Spine 27:1710-1723.
10. Li RH, Wozney JM (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 19:255-265.
11. Littlewood EA, Hattenberger M, Zak O, O'Reilly T (1997) Effect of combination therapy of rifampicin and azithromycin on TNF levels during a rat model of chronic osteomyelitis. J Antimicrob Chemother 39:493-498.
12. Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas N, Raschke M (2003) Gentamicin coating of metallic implants reduces implant related osteomyelitis in rats. Bone 32:521-531.
13. Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Stemberger A, Haas N, Raschke M (2003) A new model of implant related osteomyelitis in rats. J Biomed Mater Res 67 B: 593-602.
14. Raschke M, Wildemann B, Inden P, Bail H, Flyvbjerg A, Hoffmann J, Haas NP, Schmidmaier G (2002) Insulin-like growth factor-1 and transforming growth factor-betal accelerates osteotomy healing using polylactide-coated implants as a delivery system: a biomechanical and histological study in minipigs. Bone 30(1):144-151.
15. Raschke M, Kolbeck S, Bail H, Schmidmaier G, Flyvbjerg A, Lindner T, Dahne M, Roenne I, Haas N (2001) Homologous growth hormone accelerates healing of segmental bone defects. Bone 29:368-373.
16. Raschke MJ, Bail H, Windhagen HJ, Kolbeck SF, Weiler A, Raun K, Kappelgard A, Skiaerbaek C, Haas NP (1999) Recombinant growth hormone accelerates bone regenerate consolidation in distraction osteogenesis. Bone 24:81-88.
17. Sanderson PJ (1989) Preventing infection in orthopaedic implants. J Antimicrob Chemother 24:277-280.
18. Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, Flyvbjerg A, Haas NP, Raschke M (2001) Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-β1) from a biodegradable poly (D, L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 28:341-350.
19. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Biodegradable poly (D, L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res, Applied Biomat 58:449-455.
20. Southorn PA, Plevak DJ, Wright AJ, Wilson WR (1986) Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 61:721-724.
21. Sumner DR, Turner TM, Purchio AF, Gombotz WR, Urban RM, Galante JO (1995) Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg Am 77:1135-1147.
22. Suter F, Avai A, Fusco U, Gerundini M, Caprioli S, Maggiolo F (1994) Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 13:793-796.
23. Taylor GJ, Bannister GC, Calder S (1990) Perioperative wound infection in elective orthopaedic surgery [published erratum appears in J Hosp Infect 1991;17(2):155]. J Hosp Infect 16:241-247.
24. Wall R, Klenerman L, McCullough C, Fyfe I (1988) A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report. J Antimicrob Chemother 21(Suppl A):141-146.
25. Wood MJ (1996) The comparative efficacy and safety of teicoplanin and vancomycin [see comments] [published erratum appears in J Antimicrob Chemother 1996;38(5):919 and 1997;40(1):147]. J Antimicrob Chemother 37:209-222.
26. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA (1992) The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 74:659-670.
27. Zheng MH, Wood DJ, Papadimitriou JM (1992) What's new in the role of cytokines on osteoblast proliferation and differentiation? Pathol Res Pract 188:1104-1121.